Voyager Therapeutics' low P/S ratio may be due to anticipate...
Voyager Therapeutics' low P/S ratio may be due to anticipated poor growth or falling revenue. The company's shrinking revenue outlook is contributing to its low P/S. Without significant change, a drastic rise in stock price is hard to foresee.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000029640145feb4f1.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment